pioglitazone has been researched along with Colonic Polyps in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Colonic Polyps: Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niho, N | 1 |
| Takahashi, M | 1 |
| Shoji, Y | 1 |
| Takeuchi, Y | 1 |
| Matsubara, S | 1 |
| Sugimura, T | 1 |
| Wakabayashi, K | 1 |
1 other study available for pioglitazone and Colonic Polyps
| Article | Year |
|---|---|
Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand.
Topics: Animals; Cholesterol, LDL; Colonic Polyps; Dose-Response Relationship, Drug; Genes, APC; Hyperlipide | 2003 |